Berenberg Bank Raises Smith & Nephew (LON:SN) Price Target to GBX 2,325

Smith & Nephew (LON:SN) had its target price boosted by Berenberg Bank from GBX 2,185 ($28.74) to GBX 2,325 ($30.58) in a research report report published on Wednesday morning, Digital Look reports. Berenberg Bank currently has a buy rating on the stock.

SN has been the topic of a number of other reports. UBS Group reaffirmed a neutral rating and issued a GBX 1,800 ($23.68) price target (down from GBX 1,830 ($24.07)) on shares of Smith & Nephew in a research note on Monday, October 28th. Shore Capital reaffirmed a sell rating on shares of Smith & Nephew in a research note on Friday, January 24th. JPMorgan Chase & Co. reaffirmed a neutral rating on shares of Smith & Nephew in a research note on Wednesday, February 5th. Citigroup started coverage on shares of Smith & Nephew in a research note on Thursday, November 21st. They issued a buy rating on the stock. Finally, Credit Suisse Group decreased their price target on shares of Smith & Nephew from GBX 1,770 ($23.28) to GBX 1,725 ($22.69) and set a neutral rating on the stock in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company’s stock. Smith & Nephew presently has an average rating of Hold and a consensus target price of GBX 1,898.50 ($24.97).

LON:SN opened at GBX 1,819 ($23.93) on Wednesday. Smith & Nephew has a 52 week low of GBX 1,417 ($18.64) and a 52 week high of GBX 1,998.40 ($26.29). The company has a quick ratio of 0.96, a current ratio of 2.00 and a debt-to-equity ratio of 44.00. The stock has a market capitalization of $15.92 billion and a PE ratio of 22.82. The stock’s 50-day moving average price is GBX 1,864.86 and its 200-day moving average price is GBX 1,830.40.

About Smith & Nephew

Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Recommended Story: What is a stock split?

Analyst Recommendations for Smith & Nephew (LON:SN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.